Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 172676, 7 pages
http://dx.doi.org/10.1155/2008/172676
Review Article

Peroxisome Proliferator-Activated Receptor Delta: A Conserved Director of Lipid Homeostasis through Regulation of the Oxidative Capacity of Muscle

1Dipartimento di Scienze della Vita, Seconda Università degli Studi di Napoli, Via Vivaldi 43, 81100 Caserta, Italy
2Dipartimento delle Scienze Biologiche, Sez. Fisiologia ed Igiene, Università degli Studi di Napoli “Federico II”, Via Mezzocannone 8, 80134 Napoli, Italy
3Dipartimento di Scienze Biologiche ed Ambientali, Università degli Studi del Sannio, Via Port'Arsa 11, 82100 Benevento, Italy

Received 5 May 2008; Revised 10 July 2008; Accepted 13 August 2008

Academic Editor: Francine M. Gregoire

Copyright © 2008 Pieter de Lange et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. M. Spiegelman and J. S. Flier, “Obesity and the regulation of energy balance,” Cell, vol. 104, no. 4, pp. 531–543, 2001. View at Publisher · View at Google Scholar
  2. M. Flück and H. Hoppeler, “Molecular basis of skeletal muscle plasticity—from gene to form and function,” Reviews of Physiology, Biochemistry and Pharmacology, vol. 146, pp. 159–216, 2003. View at Publisher · View at Google Scholar
  3. S. I. Taylor, “Deconstructing type 2 diabetes,” Cell, vol. 97, no. 1, pp. 9–12, 1999. View at Publisher · View at Google Scholar
  4. P. Zimmet, K. G. M. M. Alberti, and J. Shaw, “Global and societal implications of the diabetes epidemic,” Nature, vol. 414, no. 6865, pp. 782–787, 2001. View at Publisher · View at Google Scholar
  5. P. de Lange, M. Moreno, E. Silvestri, A. Lombardi, F. Goglia, and A. Lanni, “Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms,” The FASEB Journal, vol. 21, no. 13, pp. 3431–3441, 2007. View at Publisher · View at Google Scholar
  6. C. Fürnsinn, T. M. Willson, and B. Brunmair, “Peroxisome proliferator-activated receptor-δ, a regulator of oxidative capacity, fuel switching and cholesterol transport,” Diabetologia, vol. 50, no. 1, pp. 8–17, 2007. View at Publisher · View at Google Scholar
  7. U. Risérus, D. Sprecher, T. Johnson et al., “Activation of peroxisome proliferator-activated receptor (PPAR)d promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men,” Diabetes, vol. 57, no. 2, pp. 332–339, 2008. View at Publisher · View at Google Scholar
  8. T. Tanaka, J. Yamamoto, S. Iwasaki et al., “Activation of peroxisome proliferator-activated receptor d induces fatty acid ß-oxidation in skeletal muscle and attenuates metabolic syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 15924–15929, 2003. View at Publisher · View at Google Scholar
  9. Y.-X. Wang, C.-L. Zhang, R. T. Yu et al., “Regulation of muscle fiber type and running endurance by PPARd,” PLoS Biology, vol. 2, no. 10, e294, pp. 1532–1539, 2004. View at Publisher · View at Google Scholar
  10. C.-H. Lee, P. Olson, A. Hevener et al., “PPARd regulates glucose metabolism and insulin sensitivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 9, pp. 3444–3449, 2006. View at Publisher · View at Google Scholar
  11. Z. C. Yan, D. Y. Liu, L. L. Zhang et al., “Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-d,” Biochemical and Biophysical Research Communications, vol. 354, no. 2, pp. 427–433, 2007. View at Publisher · View at Google Scholar
  12. W. He, Y. Barak, A. Hevener et al., “Adipose-specific peroxisome proliferator-activated receptor ? knockout causes insulin resistance in fat and liver but not in muscle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 15712–15717, 2003. View at Publisher · View at Google Scholar
  13. J. Berger and D. E. Moller, “The mechanisms of action of PPARs,” Annual Review of Medicine, vol. 53, no. 1, pp. 409–435, 2002. View at Publisher · View at Google Scholar
  14. E.-Z. Amri, F. Bonino, G. Ailhaud, N. A. Abumrad, and P. A. Grimaldi, “Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors,” Journal of Biological Chemistry, vol. 270, no. 5, pp. 2367–2371, 1995. View at Publisher · View at Google Scholar
  15. O. Braissant, F. Foufelle, C. Scotto, M. Dauça, and W. Wahli, “Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat,” Endocrinology, vol. 137, no. 1, pp. 354–366, 1996. View at Publisher · View at Google Scholar
  16. L. Michalik and W. Wahli, “Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions,” Current Opinion in Biotechnology, vol. 10, no. 6, pp. 564–570, 1999. View at Publisher · View at Google Scholar
  17. P. Tontonoz, E. Hu, J. Devine, E. G. Beale, and B. M. Spiegelman, “PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene,” Molecular and Cellular Biology, vol. 15, no. 1, pp. 351–357, 1995. View at Google Scholar
  18. P. de Lange, A. Feola, M. Ragni et al., “Differential 3,5,3'-triiodothyronine-mediated regulation of uncoupling protein 3 transcription: role of fatty acids,” Endocrinology, vol. 148, no. 8, pp. 4064–4072, 2007. View at Publisher · View at Google Scholar
  19. G. Solanes, N. Pedraza, R. Iglesias, M. Giralt, and F. Villarroya, “Functional relationship between MyoD and peroxisome proliferator-activated receptor-dependent regulatory pathways in the control of the human uncoupling protein-3 gene transcription,” Molecular Endocrinology, vol. 17, no. 10, pp. 1944–1958, 2003. View at Publisher · View at Google Scholar
  20. G. Krey, O. Braissant, F. L'Horset et al., “Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay,” Molecular Endocrinology, vol. 11, no. 6, pp. 779–791, 1997. View at Publisher · View at Google Scholar
  21. R. T. Nolte, G. B. Wisely, S. Westin et al., “Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-?,” Nature, vol. 395, no. 6698, pp. 137–143, 1998. View at Publisher · View at Google Scholar
  22. H. E. Xu, M. H. Lambert, V. G. Montana et al., “Molecular recognition of fatty acids by peroxisome proliferator-activated receptors,” Molecular Cell, vol. 3, no. 3, pp. 397–403, 1999. View at Publisher · View at Google Scholar
  23. S. Surapureddi, S. Yu, H. Bu et al., “Identification of a transcriptionally active peroxisome proliferator-activated receptor a-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11836–11841, 2002. View at Publisher · View at Google Scholar
  24. R. Nielsen, L. Grøntved, H. G. Stunnenberg, and S. Mandrup, “Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery,” Molecular and Cellular Biology, vol. 26, no. 15, pp. 5698–5714, 2006. View at Publisher · View at Google Scholar
  25. P. de Lange, M. Ragni, E. Silvestri et al., “Combined cDNA array/RT-PCR analysis of gene expression profile in rat gastrocnemius muscle: relation to its adaptive function in energy metabolism during fasting,” The FASEB Journal, vol. 18, no. 2, pp. 350–352, 2004. View at Google Scholar
  26. D. M. Muoio, P. S. MacLean, D. B. Lang et al., “Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) a knock-out mice. Evidence for compensatory regulation by PPARd,” Journal of Biological Chemistry, vol. 277, no. 29, pp. 26089–26097, 2002. View at Publisher · View at Google Scholar
  27. D. Holst, S. Luquet, V. Nogueira, K. Kristiansen, X. Leverve, and P. A. Grimaldi, “Nutritional regulation and role of peroxisome proliferator-activated receptor δ in fatty acid catabolism in skeletal muscle,” Biochimica et Biophysica Acta, vol. 1633, no. 1, pp. 43–50, 2003. View at Publisher · View at Google Scholar
  28. U. Dressel, T. L. Allen, J. B. Pippal, P. R. Rohde, P. Lau, and G. E. O. Muscat, “The peroxisome proliferator-activated receptor β/δ agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells,” Molecular Endocrinology, vol. 17, no. 12, pp. 2477–2493, 2003. View at Publisher · View at Google Scholar
  29. B. M. Jucker, D. Yang, W. M. Casey et al., “Selective PPARd agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study,” American Journal of Physiology, vol. 293, no. 5, pp. E1256–E1264, 2007. View at Publisher · View at Google Scholar
  30. Y.-X. Wang, C.-H. Lee, S. Tiep et al., “Peroxisome-proliferator-activated receptor d activates fat metabolism to prevent obesity,” Cell, vol. 113, no. 2, pp. 159–170, 2003. View at Publisher · View at Google Scholar
  31. J. Lin, H. Wu, P. T. Tarr et al., “Transcriptional co-activator PGC-1a drives the formation of slow-twitch muscle fibres,” Nature, vol. 418, no. 6899, pp. 797–801, 2002. View at Publisher · View at Google Scholar
  32. T. C. Leone, J. J. Lehman, B. N. Finck et al., “PGC-1a deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis,” PLoS Biology, vol. 3, no. 4, e101, pp. 672–687, 2005. View at Publisher · View at Google Scholar
  33. M. Schuler, F. Ali, C. Chambon et al., “PGC1a expression is controlled in skeletal muscles by PPARß, whose ablation results in fiber-type switching, obesity, and type 2 diabetes,” Cell Metabolism, vol. 4, no. 5, pp. 407–414, 2006. View at Publisher · View at Google Scholar
  34. S. Luquet, J. Lopez-Soriano, D. Holst et al., “Peroxisome proliferator-activated receptor d controls muscle development and oxidative capability,” The FASEB Journal, vol. 17, no. 15, pp. 2299–2301, 2003. View at Publisher · View at Google Scholar
  35. B. Brunmair, K. Staniek, J. Dörig et al., “Activation of PPAR-d in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids,” Diabetologia, vol. 49, no. 11, pp. 2713–2722, 2006. View at Publisher · View at Google Scholar
  36. D. Constantin, D. Constantin-Teodosiu, R. Layfield, K. Tsintzas, A. J. Bennett, and P. L. Greenhaff, “PPARδ agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle,” Journal of Physiology, vol. 583, no. 1, pp. 381–390, 2007. View at Publisher · View at Google Scholar
  37. I. G. Lunde, M. Ekmark, Z. A. Rana, A. Buonanno, and K. Gundersen, “PPARδ expression is influenced by muscle activity and induces slow muscle properties in adult rat muscles after somatic gene transfer,” Journal of Physiology, vol. 582, no. 3, pp. 1277–1287, 2007. View at Publisher · View at Google Scholar
  38. D. K. Krämer, L. Al-Khalili, B. Guigas, Y. Leng, P. M. Garcia-Roves, and A. Krook, “Role of AMP kinase and PPARδ in the regulation of lipid and glucose metabolism in human skeletal muscle,” Journal of Biological Chemistry, vol. 282, no. 27, pp. 19313–19320, 2007. View at Publisher · View at Google Scholar
  39. P. J. Randle, P. B. Garland, C. N. Hales, and E. A. Newsholme, “The glucose fatty-acid cycle. Its role in isulin sensitivity and the metabolic disturbances of diabetes mellitus,” The Lancet, vol. 281, no. 7285, pp. 785–789, 1963. View at Publisher · View at Google Scholar
  40. P. Escher, O. Braissant, S. Basu-Modak, L. Michalik, W. Wahli, and B. Desvergne, “Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding,” Endocrinology, vol. 142, no. 10, pp. 4195–4202, 2001. View at Publisher · View at Google Scholar
  41. K. Tsintzas, K. Jewell, M. Kamran et al., “Differential regulation of metabolic genes in skeletal muscle during starvation and refeeding in humans,” Journal of Physiology, vol. 575, no. 1, pp. 291–303, 2006. View at Publisher · View at Google Scholar
  42. D. Holst, S. Luquet, V. Nogueira, K. Kristiansen, X. Leverve, and P. A. Grimaldi, “Nutritional regulation and role of peroxisome proliferator-activated receptor δ in fatty acid catabolism in skeletal muscle,” Biochimica et Biophysica Acta, vol. 1633, no. 1, pp. 43–50, 2003. View at Publisher · View at Google Scholar
  43. P. de Lange, P. Farina, M. Moreno et al., “Sequential changes in the signal transduction responses of skeletal muscle following food deprivation,” The FASEB Journal, vol. 20, no. 14, pp. 2579–2581, 2006. View at Google Scholar
  44. T. Furuyama, K. Kitayama, H. Yamashita, and N. Mori, “Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation,” Biochemical Journal, vol. 375, part 2, pp. 365–371, 2003. View at Publisher · View at Google Scholar
  45. M. C. Sugden, R. M. Howard, M. R. Munday, and M. J. Holness, “Mechanisms involved in the coordinate regulation of strategic enzymes of glucose metabolism,” Advances in Enzyme Regulation, vol. 33, pp. 71–95, 1993. View at Publisher · View at Google Scholar
  46. J. Lin, C. Handschin, and B. M. Spiegelman, “Metabolic control through the PGC-1 family of transcription coactivators,” Cell Metabolism, vol. 1, no. 6, pp. 361–370, 2005. View at Publisher · View at Google Scholar
  47. M. J. Watt, R. J. Southgate, A. G. Holmes, and M. A. Febbraio, “Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) α and δ and PPAR coactivator 1α in human skeletal muscle, but not lipid regulatory genes,” Journal of Molecular Endocrinology, vol. 33, no. 2, pp. 533–544, 2004. View at Publisher · View at Google Scholar
  48. D. J. Mahoney, G. Parise, S. Melov, A. Safdar, and M. A. Tarnopolsky, “Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise,” The FASEB Journal, vol. 19, no. 11, pp. 1498–1500, 2005. View at Publisher · View at Google Scholar
  49. D. A. Hood, “Invited review: contractile activity-induced mitochondrial biogenesis in skeletal muscle,” Journal of Applied Physiology, vol. 90, no. 3, pp. 1137–1157, 2001. View at Google Scholar
  50. B. H. Goodpaster, A. Katsiaras, and D. E. Kelley, “Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity,” Diabetes, vol. 52, no. 9, pp. 2191–2197, 2003. View at Publisher · View at Google Scholar
  51. J. E. Kuhl, N. B. Ruderman, N. Musi et al., “Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle,” American Journal of Physiology, vol. 290, no. 6, pp. E1296–1303, 2006. View at Publisher · View at Google Scholar
  52. Z. Nahlé, M. Hsieh, T. Pietka et al., “CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPARd/ß-mediated adaptation to metabolic stress,” The Journal of Biological Chemistry, vol. 283, no. 21, pp. 14317–14326, 2008. View at Publisher · View at Google Scholar
  53. C. Ravinet-Trillou, C. Delgorge, C. Menet, M. Arnone, and P. Soubrié, “CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity,” International Journal of Obesity, vol. 28, no. 4, pp. 640–648, 2004. View at Publisher · View at Google Scholar